Abstract
A rapid and accurate method to quantify ochratoxin A (OTA) at ppt (pg/ml) levels in urine has been developed. The method uses commercial immunoaffinity columns for clean-up and reversed phase high-performance liquid chromatography (HPLC) with fluorescence detector for quantification of the toxin. Average recoveries of OTA from human urine spiked at levels from 0.05 ng/ml to 1.0 ng/ml ranged from 88% to 93%, with relative standard deviations (RSDs) between 1% and 8%. Detection limit was 0.005 ng/ml. Out of 41 human urine samples, 25 were found positive to OTA with only one sample exceeding 0.05 ng/ml; the latter originated from a patient affected by karyomegalic interstitial nephritis. The method can be used as a rapid and non-invasive tool to assess human and animal exposure to OTA in epidemiological studies and to establish the possible role of OTA in acute animal intoxications or human end-stage renal diseases.
Similar content being viewed by others
References
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 56. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, International Agency for Research on Cancer, Lyon, 1993: 489-521.
Jorgensen K. Survey of pork, poultry, coffee, beer and pulses for ochratoxin A. Food Addit Contam 1998; 15(5): 550-554.
Trucksess MW, Giler J, Young K, White KD, Page SW. Determination and survey of ochratoxin A in wheat, barley and coffee-1997. J Assoc Off Anal Chem Int 1999; 82(1): 85-89.
Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, eds.Mycotoxins, endemic nephropathy and urinary tract tumours. IARC Scientific Publications No. 115, Oxford University Press, Oxford, UK, 1991.
Maaroufi K, Achour A, Hammami M, El May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. Ochratoxin A in human blood in relation to nephropathy in Tunisia. Human Exp Toxicol 1995; 14: 609-615.
Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, El-Gayar HAM, Betbeder AM, Creppy EE. Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Human Exp Toxicol 1998; 17: 124-129.
Schlatter C, Studer-Rohr J, Rasonyi T. Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 1996; 13 Supplement: 43-44.
Breitholtz-Emanuelsson A, Minervini F, Hult K, Visconti A. Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Natural Toxins 1994; 2: 366-370.
Scott PM, Kanhere SR, Lau BP-Y, Lewis DA, Hayward S, Ryan JJ, Kuiper-Goodman T. Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 1998; 15(5): 555-562.
Radic B, Fuchs R, Peraica M, Lucic A. Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Letters 1997; 91: 105-109.
Petkova-Bocharova T, Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, eds. Mycotoxins, endemic nephropathy and urinary tract tumors. IARC Scientific Publications No. 115, Oxford University Press, Oxford, UK, 1991: 135-137.
Storen O, Holm H, Stormer F. Metabolism of ochratoxin A by rats. Applied Environ Microbiol 1982; 44(4): 785-789.
Scientific Committee on Food, Opinion on Ochratoxin A, CS/CNTM/MYC/14 final, Annex II to document XXIV/2210/98, European Commission, Brussels, 28 September 1998.
Castegnaro M, Maru V, Maru G, Ruiz-Lopez MD. High-performance liquid chromatographic determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine. Analyst 1990; 115: 129-131.
Orti DL, Hill RH, Liddle JA, Needham LL. High performance liquid chromatography of mycotoxin metabolites in human urine. J. Anal. Toxicol. 1986; 10(2): 41-45.
MacDonald SJ, Langton S, Brereton PA. Assessment of human exposure to ochratoxin A in the UK-Relationship between dietary intake and plasma and urine levels. In: de Koe WJ, Samson RA, van Egmond HP, Gilbert J, Sabino M, eds. Mycotoxins and Phycotoxins in perspective at the turn of the millenium, Proceedings of the X International IUPAC Symposium on Mycotoxins and Phycotoxins, 21-25 May 2000 Guarujà (Brazil), Printed by Ponsen & Looyen, Wageningen, The Netherlands, 2001: 181-188.
Valenta H, Kune I, Rohr K. Determination of ochratoxin A in urine and faeces of swine by high-performance liquid chromatography. J Chromatogr B 1993; 613: 295-302.
Scott PM, Trucksess MW. Application of immunoaffinity columns to mycotoxin analysis. J. Assoc Off Anal Chem Int 1997; 80(5): 941-949.
Kussak A, Andersson B, Andersson K. Immunoaffinity column clean-up for the high-performance liquid chromatographic determination of aflatoxins B1, B2, G1, G2, M1 and Q1 in urine. J Chromatogr B 1995; 672: 253-259.
Godin M, Francois A, Le Roy F, Morin JP, Creppy EE, Hemet J, Fillastre JP. Kariomegalic Interstitial Nephritis. Am J Kidney Dis 1996; 27(1): 166.
Maaroufi K, Zakhama A, Baudrimont I, Achour A, Abid S, Ellouz F, Dhouib SW, Creppy EE, Bacha H. Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Human Exp Toxicol 1999; 18: 410-415.
Castegnaro M, Maru V, Petkova-Bocharova T, Nikolov I, Bartsch H. Concentration of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: lack of detection of 4-hydroxyochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H, eds. Mycotoxins, endemic nephropathy and urinary tract tumors. IARC Scientific Publications No. 115, Oxford University Press, Oxford, UK, 1991: 165-169.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pascale, M., Visconti, A. Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high-performance liquid chromatography. Mycopathologia 152, 91–95 (2001). https://doi.org/10.1023/A:1012463227948
Issue Date:
DOI: https://doi.org/10.1023/A:1012463227948